- Home
- Products
- Customized FluoroAb™
- C5
- Eculizumab-Fluoresein
Eculizumab-Fluoresein (CAT#: ADC-FL-250)
This product is comprised of an anti-C5 monoclonal antibody (Eculizumab) labeled with Fluoresein. Fluoresein is a fluorescent dye and it's excitation/emission is 490/525 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 IgG2/G4-kappa antibody, Eculizumab
- Generic name
- Eculizumab
- Species Reactivity
- Human
- Name
- Fluoresein
- Excitation⁄Emission (nm)
- 490/525
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-VEGFA MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3794)
- Tucotuzumab-iFluor 532 (CAT#: ADC-FL-1282)
- Anti-CD19 MAb (Clone 15)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11687)
- Anti-FGFR2 MAb (Clone 6)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9484)
- Anti-OxLDL MAb (Clone 1)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3819)
- Anti-CD74 MAb (Clone 2)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12548)
- Anti-PDCD1 MAb (Clone 14)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9151)
- Anti-ERBB2 MAb (Clone 13)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15746)
- Anti-TNFRSF10B MAb (Clone 4)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5324)
- Anti-IgG Fc MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12868)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-250. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-739 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-732 | Anti-C5 (Eculizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-731 | Anti-C5 (Eculizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-735 | Anti-C5 (Pexelizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
